G1 Therapeutics, Inc. (G1therapeutics)

Oncology Corporate Profile

HQ Location

79 T.W. Alexander Drive
4401 Research Commons, Suite 105
Research Triangle Park, NC 27709

Company Description

G1 Therapeutics, Inc. is a privately held clinical-stage pharmaceutical company based in Research Triangle Park, NC that focuses on the discovery and development of novel, small-molecule therapies to address significant unmet needs in oncology. The company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug candidates that address two markets: CDK4/6 antineoplastics and protection of the bone marrow and immune system from damage by chemotherapy (chemoprotection).

Website: http://www.g1therapeutics.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
trilaciclib (+ carboplatin and etoposide) / G1T28CDK4/6 inhibitor1st line Small Cell Lung Cancer (SCLC)II
trilaciclib (+ topotecan) / G1T28CDK4/6 inhibitor2nd and 3rd line Small Cell Lung Cancer (SCLC)II
G1T38CDK4/6 inhibitorBreast cancerII
trilaciclib / G1T28CDK4/6 inhibitorTriple negative Breast cancerII
G1T48CDK4/6 inhibitorBreast cancerPreclinical

View additional information on product candidates here »

Source: http://www.g1therapeutics.com

Recent News Headlines

There are no news items to display